Retinopathy of Prematurity:Summary of a Decade

Sponsor

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi (Other)

Overall Status

Completed

CT.gov ID

NCT01363960

Collaborator

(none)

609

Enrollment

Location

141

Duration (Months)

4.3

Patients Per Site Per Month

Study Details

The aim of the study is to evaluate our 10 year experience of retinopathy of prematurity screening.

Condition or Disease	Intervention/Treatment	Phase
Retinopathy of Prematurity

Study Type:

Observational

Actual Enrollment :

609 participants

Study Start Date :

Mar 1, 1999

Actual Primary Completion Date :

Dec 1, 2010

Actual Study Completion Date :

Dec 1, 2010

Arm	Intervention/Treatment
neonates with retinopathy of prematurity all neonates meet the criteria: a BW of less than 1501 gram (g) born at a GA of 34 weeks (wk) or less and selected infants with an unstable clinical course were included

Number of neonates developed retinopathy of prematurity [ten years]
risk factors contributing to ROP development [ten years]
mechanic ventilation. oxygen therapy, respiratory distress syndrome, sepsis, intraventricular, hemorrhage, blood transfusion v.s

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Neonates either with a BW of less than 1501 gram (g) or born at a GA of 34 weeks (wk) or less
selected infants with an unstable clinical course were included